ICH M10 on bioanalytical method validation - Scientific guideline
Submitted by Anonymous (not verified) on 3 May 2024 - 9:45
ICH M10 on bioanalytical method validation - Scientific guideline
Plasma master file certificates
Submitted by Anonymous (not verified) on 3 May 2024 - 9:45
Plasma master file certificates
Real-world evidence
Submitted by Anonymous (not verified) on 3 May 2024 - 8:55
Real-world evidence
Big data
Submitted by Anonymous (not verified) on 3 May 2024 - 8:55
Big data
Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence
Submitted by Anonymous (not verified) on 3 May 2024 - 8:50
Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence
Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline
Submitted by Anonymous (not verified) on 3 May 2024 - 8:50
Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline
Template for scientific document (part B-F)
Submitted by Anonymous (not verified) on 2 May 2024 - 15:29
Template for scientific document (part B-F)
CVMP Interested Parties’ meeting, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2024, 17:00 (CEST) to 22 May 2024, 19:00 (CEST)
Submitted by Anonymous (not verified) on 2 May 2024 - 15:26
CVMP Interested Parties’ meeting, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2024, 17:00 (CEST) to 22 May 2024, 19:00 (CEST)
Scientific recommendations on classification of advanced therapy medicinal products
Submitted by Anonymous (not verified) on 2 May 2024 - 15:26
Scientific recommendations on classification of advanced therapy medicinal products
Appendix 1: Acceptable intakes established for N-nitrosamines
Submitted by Anonymous (not verified) on 2 May 2024 - 15:12
Appendix 1: Acceptable intakes established for N-nitrosamines